NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 115 filers reported holding NURIX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,809 | -21.3% | 357,287 | 0.0% | 0.01% | -25.0% |
Q2 2023 | $3,569 | +12.5% | 357,287 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $3,173 | -19.1% | 357,287 | 0.0% | 0.01% | -20.0% |
Q4 2022 | $3,923 | -99.9% | 357,287 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $4,655,000 | +20.5% | 357,287 | +17.1% | 0.01% | +20.0% |
Q2 2022 | $3,864,000 | -9.6% | 305,013 | 0.0% | 0.01% | +11.1% |
Q1 2022 | $4,274,000 | -51.6% | 305,013 | +0.1% | 0.01% | -50.0% |
Q4 2021 | $8,823,000 | -10.4% | 304,762 | -7.3% | 0.02% | -14.3% |
Q3 2021 | $9,845,000 | +21.8% | 328,619 | +7.8% | 0.02% | +16.7% |
Q2 2021 | $8,085,000 | -14.7% | 304,762 | 0.0% | 0.02% | -21.7% |
Q1 2021 | $9,475,000 | – | 304,762 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
AtonRa Partners | 24,227 | $190,424 | 0.40% |
WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |